MedTrace Logo

Persistence of Immune Response After Vaccination With Influenza Vaccine

NCT01906190 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2013-07-24

No results posted yet for this study

Summary

This clinical study will be performed in subjects aged 12-60 years old enrolled in NCT01310374 who received 2010 seasonal influenza vaccine to evaluate the persistence of the immune response of influenza vaccine up to 24 months after vaccination.

Conditions

  • Influenza, Human
  • Immunisation Reaction

Interventions

BIOLOGICAL

seasonal influenza vaccine

subjects whose antibodies less than 1:40 6 months later after primary vaccination will receive a booster dose of seasonal influenza vaccine

Sponsors & Collaborators

  • Centers for Disease Control and Prevention, China

    lead OTHER_GOV

Principal Investigators

  • jiang wu, Bachelor · Beijing Centers for Disease Control and Prevention

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-03-31
Completion
2013-07-31

Countries

  • China

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01906190 on ClinicalTrials.gov